Polyrizon Ltd.
Polyrizon Ltd. (PLRZ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PLRZ · as of Jun 8, 2026
Key Statistics
Explore Polyrizon Ltd. Data
plrz stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
plrz competitorsPLRZ
AIM
CYCN
KTTA
NBY
PMCBStock Performance
Full HistoryAbout Polyrizon Ltd.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier w…
what is polyrizon ltd. · plrz stock overview · polyrizon ltd. company profile · who is polyrizon ltd. ceo · plrz NASDAQ · polyrizon ltd. headquarters · polyrizon ltd. business segments
About Stock Overview & Key Data
Polyrizon Ltd. (PLRZ) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 29, 2024. As of the latest trading session, PLRZ stock price is $12.52, with a market capitalization of $14.0M. The stock has returned +149.40% over the past 12 months and +47.47% year-to-date.
In fiscal year 2025, Polyrizon Ltd. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Polyrizon Ltd. (PLRZ) stock price is $12.52. The stock is traded on NASDAQ under the ticker symbol PLRZ. The 52-week range is $2.88 – $18.20.